XBiotech shares crater as CHMP shudders at its application to sell Xilonix
It’s possible Austin-based XBiotech just doesn’t get it.
The EMA’s Committee for Medicinal Products for Human Use — the CHMP — put together an informal trend vote …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
